ODAC reviewed Imfinzi in resectable lung cancer
26 July 2024
FDA Advisory Committee reviewed Imfinzi for treatment of resectable non-small cell lung cancer based on AEGEAN Phase III trial results
The…
78,250€
0,97%
Echtzeit-Aktienkurs Astrazeneca PLC (Spons. ADRs)
Bid:
Ask:
Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie
Pharma Stock Roundup: AZN, SNY, ABBV Q2 Earnings, PFE & MRKs Positive Pipeline News
AstraZeneca (AZN), Sanofi (SNY) and AbbVie (ABBV) announce second-quarter results. Merck (MRK) and Pfizers (PFE) phase III studies achieve primary…
AstraZeneca PLC (AZN) Q2 2024 Earnings Call Transcript
…
AstraZeneca Plc (AZN) Q2 2024 Earnings Call Transcript
AZN earnings call for the period ending June 30, 2024.…
AstraZeneca, Roche Intensify New Drug Push, Automakers Sink Post-Earnings | The Opening Trade 07/25
2 and half trillion dollar Thursday. Thats the market cap of firms reporting on the busiest day for European earnings.…